Novel armed oncolytic HSV exhibits strong antitumor effects that lead to complete tumor regression

被引：0
|
作者：
Abdelmoneim, Mohamed A. [1 ,2 ,3 ]
Naoe, Yoshinori [1 ]
Eissa, Ibrahim R. [1 ,2 ]
Aboalela, Mona A. [1 ,2 ,4 ]
Matsumura, Shigeru [1 ]
Tanaka, Maki [5 ]
Kasuya, Hideki [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Canc Immune Therapy Res Ctr, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Surg 2, Nagoya, Aichi, Japan
[3] Zagazig Univ, Dept Micro, Fac Vet Med, Zagazig, Egypt
[4] Zagazig Univ, Micro & Immunol Dept, Fac Med, Zagazig, Egypt
[5] Takara Bio Inc, Kusatsu, Shiga, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3049
引用
收藏
页码：1855 / 1855
页数：1
相关论文
共 50 条
  • [1] An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer
    Zhao, Jiliang
    Wang, Han
    Chen, Jinhua
    Wang, Chunlei
    Gong, Nanxin
    Zhou, Feilong
    Li, Xin
    Cao, Youjia
    Zhang, Hongkai
    Wang, Wei
    Zheng, Hao
    Zhang, Cuizhu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 718
  • [2] Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model
    Li, Hongtao
    Dutuor, Aurelie
    Fu, Xinping
    Zhang, Xiaoliu
    JOURNAL OF GENE MEDICINE, 2007, 9 (03): : 161 - 169
  • [3] EXPERIMENTAL BRAIN TUMOR THERAPY USING ONCOLYTIC HSV-1 ARMED WITH INTERLEUKIN 12
    Todo, Tomoki
    Fukuhara, Hiroshi
    Miyamoto, Shinya
    Guan, Yi
    Ino, Yasushi
    NEURO-ONCOLOGY, 2009, 11 (02) : 223 - 223
  • [4] Novel Oncolytic HSV Armed with Platelet Factor 4, an Antiangiogenic Agent, Shows Enhanced Efficacy
    Liu, Ta-Chiang
    Zhang, Tingguo
    Fukuhara, Hiroshi
    Kuroda, Toshi
    Todo, Tomoki
    Martuza, Robert L.
    Rabkin, Samuel D.
    Kurtz, Andreas
    MOLECULAR THERAPY, 2006, 13 : S62 - S62
  • [5] Combination treatment of bevacizumab and oncolytic HSV armed with angiostatin show enhanced antitumoral and antiangiogenic effects
    Zhang, Wei
    Fulci, Giulia
    Rabkin, Samuel D.
    Zhang, Xiang
    Martuza, Robert L.
    CANCER RESEARCH, 2011, 71
  • [6] Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors
    Kwan, Amy
    Winder, Natalie
    Atkinson, Emer
    Al-Janabi, Haider
    Allen, Richard J.
    Hughes, Russell
    Moamin, Mohammed
    Louie, Rikah
    Evans, Dhanajay
    Hutchinson, Matthew
    Capper, Drew
    Cox, Katie
    Handley, Joshua
    Wilshaw, Adam
    Kim, Taewoo
    Tazzyman, Simon J.
    Srivastava, Sanjay
    Ottewell, Penelope
    Vadakekolathu, Jayakumar
    Pockley, Graham
    Lewis, Claire E.
    Brown, Janet E.
    Danson, Sarah J.
    Conner, Joe
    Muthana, Munitta
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (03) : 589 - 601
  • [7] Oncolytic virotherapy: Approaches to tumor targeting and enhancing antitumor effects
    Thorne, SH
    Hermiston, T
    Kirn, D
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : 537 - 548
  • [8] Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer
    Ma, Shuai
    Qu, Wenzhi
    Mao, Liang
    Zhu, Zhi
    Jia, Lanling
    Zhao, Lei
    Zheng, Xinyu
    ONCOLOGY REPORTS, 2012, 27 (05) : 1443 - 1450
  • [9] Armed oncolytic adenovirus with an antiangiogenic gene, sflt-1:: A novel effective antitumor approach
    Zhang, ZL
    Wang, JH
    Zou, WG
    Li, BH
    Pei, ZF
    Gu, JF
    Qian, C
    Liu, XY
    MOLECULAR THERAPY, 2004, 9 : S171 - S171
  • [10] Combination of IAP Antagonists and INF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
    Beug, Shawn T.
    Pichette, Stephanie J.
    St-Jean, Martine
    Holbrook, Janelle
    Walker, Danielle E.
    LaCasse, Eric C.
    Korneluk, Robert G.
    MOLECULAR THERAPY-ONCOLYTICS, 2018, 10 : 28 - 39
12345